OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations
William M. Showers, Sonia M. Leach, Katerina Kechris, et al.
Infection Genetics and Evolution (2021) Vol. 97, pp. 105153-105153
Open Access | Times Cited: 24

Showing 24 citing articles:

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
Charlotte Hedskog, Lauren Rodriguez, Pavitra Roychoudhury, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 9, pp. 1263-1273
Open Access | Times Cited: 15

Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron Variants
Lauren Rodriguez, J. Lizbeth Reyes Zamora, Dong Han, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 168-168
Open Access

Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
Anja Kolarič, Marko Jukič, Urban Bren
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 165-165
Open Access | Times Cited: 26

Seasonal effects decouple SARS-CoV-2 haplotypes worldwide
Tre Tomaszewski, Muhammad Asif Ali, Kelsey Caetano-Anollés, et al.
F1000Research (2023) Vol. 12, pp. 267-267
Open Access | Times Cited: 10

The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro
Yue Shen, William Eades, William Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 9, pp. 1151-1160
Open Access | Times Cited: 17

Superantigens and SARS-CoV-2
Adam Hamdy, Anthony Leonardi
Pathogens (2022) Vol. 11, Iss. 4, pp. 390-390
Open Access | Times Cited: 16

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials
Charlotte Hedskog, Christoph D. Spinner, Ulrike Protzer, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 546-546
Open Access | Times Cited: 2

A New Way to Trace SARS-CoV-2 Variants Through Weighted Network Analysis of Frequency Trajectories of Mutations
Qiang Huang, Qiang Zhang, Paul W. Bible, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11

SARS-CoV-2: analysis of the effects of mutations in non-structural proteins
Kavya Senthilazhagan, Seshagiri Sakthimani, Deepthi Kallanja, et al.
Archives of Virology (2023) Vol. 168, Iss. 7
Closed Access | Times Cited: 6

Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance
Qiang Huang, Huining Qiu, Paul W. Bible, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
Chad D. Fibke, Yayuk Joffres, John R. Tyson, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7

The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality
Tre Tomaszewski, Volker Gürtler, Kelsey Caetano-Anollés, et al.
Methods in microbiology (2022), pp. 233-268
Open Access | Times Cited: 7

Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2
Ruba Al Khalaf, Anna Bernasconi, Pietro Pinoli, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4238-4250
Open Access | Times Cited: 5

VariantHunter: a method and tool for fast detection of emerging SARS-CoV-2 variants
Pietro Pinoli, Arif Canakoglu, Stefano Ceri, et al.
Database (2023) Vol. 2023
Open Access | Times Cited: 2

Phylogeogenomic analysis of the earliest reported sequences of SARS‐CoV‐2 from 161 countries
Rezwanuzzaman Laskar, Mehboob Hoque, Safdar Ali
Apmis (2024)
Closed Access

SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants
Lauren Rodriguez, Hery W. Lee, Jiani Li, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access

The SARS-CoV-2 Omicron Variant of Concern and its Rapid Spread throughout the Western Brazilian Amazon
Gabriella Sgorlon-Oliveira, Jackson Alves da Silva Queiroz, Nadson Willian Felipe Gasparelo, et al.
(2022)
Open Access | Times Cited: 3

Data-Driven Methods for Viral Variants’ Identification
Anna Bernasconi
Elsevier eBooks (2024)
Closed Access

Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021
Shannon Harger Payen, Andrew Gorzalski, Danielle Denise Siao, et al.
Infection Genetics and Evolution (2023) Vol. 111, pp. 105434-105434
Open Access | Times Cited: 1

SARS-COV-2: Analysis of mutational impacts on non-structural proteins
Kavya Senthilazhagan, Seshagiri Sakthimani, Deepthi Kallanja, et al.
Research Square (Research Square) (2023)
Open Access

Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study
Archana Chinnamadhu, Jaganathan Ramakrishnan, Suganya Suresh, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 4283-4296
Closed Access

Page 1

Scroll to top